Subodh Verma


Scientist, Keenan Research Centre for Biomedical Science


Dr. Subodh Verma is a cardiac surgeon-scientist at St. Michael’s Hospital, Professor at the University of Toronto and the Canada Research Chair in Atherosclerosis. He has been on the India Abroad Power List, recognized as one of Canada’s Top 40 under 40, and honoured with the Howard Morgan Award from the International Academy of Cardiovascular Sciences and the Royal College of Physicians and Surgeons of Canada Gold Medal in Surgery. He is a member of the Royal Society of Canada College of New Scholars, Artists and Scientists, and an inductee of the American Association of Thoracic Surgeons. Dr. Verma runs a practice that encompasses the entire spectrum of adult cardiac surgery (with a special interest in mitral valve repair and bicuspid aortopathy).

He is involved in several clinical trials and oversees a dynamic pre-clinical research laboratory that focuses on the roles of risk factors, inflammation and autophagy in cardiovascular health. His innovative research has culminated in nearly 300 peer-reviewed papers and two United States patents. Dr. Verma’s meta-analysis revealing that bypass surgery is superior to angioplasty in patients with diabetes has been used by the American College of Cardiology and the Canadian Cardiovascular Society (CCS) to shape the recommendations around the best clinical choice for revascularization procedures involving individuals with diabetes. He has contributed to the CCS guidelines for antiplatelet therapy, atrial fibrillation, dyslipidemia, peripheral arterial disease, and stable coronary artery disease; Canadian Cardiovascular Surgery Position Statement and Canadian Cardiometabolic Risk Position Paper. Dr. Verma spearheads the CARDIOLINK platform that will conduct clinical trials in atrial fibrillation, aneurysm and cerebral protection, diabetes and secondary prevention, valvular heart disease, and critical limb ischemia. He (co-)founded and (co-)chairs many regional and national educational initiatives that include the Landmark Lecture, State of the Heart Symposium, Toronto Acute Coronary Syndrome Summit, St. Michael’s Heart Valve Summit, Advances in Cardiology, Current Issues in Cardiology, and At the Heart of Diabetes programs.


Recent Publications

  1. Cherney, DZI, Verma, S, Parker, JD. Dulaglutide and renal protection in type 2 diabetes. Lancet Diabetes Endocrinol. 2018; :. doi: 10.1016/S2213-8587(18)30125-6. PubMed PMID:29910025 .
  2. Farkouh, ME, Verma, S. Prevention of Heart Failure With SGLT-2 Inhibition: Insights From CVD-REAL. J. Am. Coll. Cardiol. 2018;71 (22):2507-2510. doi: 10.1016/j.jacc.2018.02.078. PubMed PMID:29852974 .
  3. Syed, MH, Hussain, MA, Khoshhal, Z, Salata, K, Altuwaijri, B, Hughes, B et al.. Thirty-day hospital readmission and emergency department visits after vascular surgery: a Canadian prospective cohort study. Can J Surg. 2018;61 (4):12417. . PubMed PMID:29806807 .
  4. Bajaj, HS, Abouhassan, T, Ahsan, MR, Arnaout, A, Hassanein, M, Houlden, RL et al.. Diabetes Canada Position Statement for People with Types 1 and 2 Diabetes Who Fast During Ramadan. Can J Diabetes. 2018; :. doi: 10.1016/j.jcjd.2018.04.007. PubMed PMID:29804943 .
  5. Hussain, MA, Al-Omran, M, Creager, MA, Anand, SS, Verma, S, Bhatt, DL et al.. Antithrombotic Therapy for Peripheral Artery Disease: Recent Advances. J. Am. Coll. Cardiol. 2018;71 (21):2450-2467. doi: 10.1016/j.jacc.2018.03.483. PubMed PMID:29793635 .
  6. Verma, S, Mathew, V, Farkouh, ME. Targeting Inflammation in the Prevention and Treatment of Type 2 Diabetes: Insights From CANTOS. J. Am. Coll. Cardiol. 2018;71 (21):2402-2404. doi: 10.1016/j.jacc.2018.03.480. PubMed PMID:29793628 .
  7. Verma, S, Mazer, CD, Fitchett, D, Inzucchi, SE, Pfarr, E, George, JT et al.. Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME® randomised trial. Diabetologia. 2018; :. doi: 10.1007/s00125-018-4644-9. PubMed PMID:29777264 .
  8. Verma, S, Bhatt, DL, Bain, SC, Buse, JB, Mann, JFE, Marso, SP et al.. Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER Trial. Circulation. 2018;137 (20):2179-2183. doi: 10.1161/CIRCULATIONAHA.118.033898. PubMed PMID:29760228 .
  9. Yanagawa, B, Elbatarny, M, Verma, S, Hill, S, Mazine, A, Puskas, JD et al.. Surgical Management of Tricuspid Valve Infective Endocarditis: A Systematic Review and Meta-Analysis. Ann. Thorac. Surg. 2018; :. doi: 10.1016/j.athoracsur.2018.04.012. PubMed PMID:29750928 .
  10. Verma, A, Ha, ACT, Rutka, JT, Verma, S. What Surgeons Should Know About Non-Vitamin K Oral Anticoagulants: A Review. JAMA Surg. 2018; :. doi: 10.1001/jamasurg.2018.0374. PubMed PMID:29710221 .
Search PubMed

Affiliations & Other Activities

  • Staff Surgeon, Division of Cardiology , St. Michael’s Hospital
  • Professor, Department of Surgery and Pharmacology & Toxicology, University of Toronto